Mackinnon, Alison

Galectin-3 Expression and Secretion Links Macrophages to the Promotion of Renal Fibrosis

Henderson, N. C., Mackinnon, A. C., Farnworth, S. L., Kipari, T., Haslett, C., Iredale, J. P., Liu, F.-T., Hughes, J., & Sethi, T. (2008) · The American Journal of Pathology

Galectins and Cancer BiologyChronic Kidney Disease and Diabetes

Cited by 562

Hepatic progenitor cells of biliary origin with liver repopulation capacity

Lu, W.-Y., Bird, T. G., Boulter, L., Tsuchiya, A., Cole, A. M., Hay, T., Guest, R. V., Wojtacha, D., Man, T. Y., Mackinnon, A., et al. (2015) · Nature Cell Biology

Liver physiology and pathologyMesenchymal stem cell research

Cited by 479

Ly6Chi monocytes direct alternatively activated profibrotic macrophage regulation of lung fibrosis

Gibbons, M. A., MacKinnon, A. C., Ramachandran, P., Dhaliwal, K., Duffin, R., Phythian-Adams, A. T., van Rooijen, N., Haslett, C., Howie, S. E., Simpson, A. J., et al. (2011) · American Journal of Respiratory and Critical Care Medicine

Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisTransplantation: Methods and Outcomes

Cited by 466

Alternatively activated macrophages promote resolution of necrosis following acute liver injury

Starkey Lewis, P., Campana, L., Aleksieva, N., Cartwright, J. A., Mackinnon, A., O'Duibhir, E., Kendall, T., Vermeren, M., Thomson, A., Gadd, V., et al. (2020) · Journal of Hepatology

Drug-Induced Hepatotoxicity and ProtectionLiver physiology and pathology

Cited by 209

The therapeutic potential of galectin-3 inhibition in fibrotic disease

Slack, R. J., Mills, R., & Mackinnon, A. C. (2021) · The International Journal of Biochemistry & Cell Biology

Galectins and Cancer BiologyCardiac Fibrosis and Remodeling

Cited by 136

Patients with the worst outcomes after paracetamol (acetaminophen)‐induced liver failure have an early monocytopenia

Moore, J. K., MacKinnon, A. C., Man, T. Y., Manning, J. R., Forbes, S. J., & Simpson, K. J. (2017) · Alimentary Pharmacology & Therapeutics

Drug-Induced Hepatotoxicity and ProtectionLiver Disease and Transplantation

Cited by 28

Development of a multi-biomarker risk score based on serum proteins by the Prognostic Lung Fibrosis Consortium (PROLIFIC)

Schafer, P., Rassa, J., Seyda, A., Hersey, S., Eisinger, D., Melin, J., Bencher, R., Neighbors, M., Mouded, M., Turner, S., et al. (2024) · Idiopathic interstitial pneumonias

Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisChronic Obstructive Pulmonary Disease (COPD) Research

Cited by 0